![]() |
![]() |
||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
Figure 3: The technology developed by Celtaxsys is presently being applied to four therapeutic areas, each of which can be viewed from a perspective of defective immune cell migration. The therapeutic resolution of these diseases is achieved by introduction or removal of a cell migration agent, as indicated.
![]() |
|||||||||||||||||||||||||||||||||||||
|
Home
|
Technology
|
Management
|
Investors
|
Careers
|
Contact
|
Privacy Policy
|
Terms of Use
|
||||||||||||||||||||||||||||||
| Copyright © 2008 Celtaxsys. All rights reserved. | |||||||||||||||||||||||||||||||||||||